240 related articles for article (PubMed ID: 18312929)
1. Consumption of dietary supplements and over-the-counter and prescription medications in men participating in the Prostate Cancer Prevention Trial at an academic center.
Grainger EM; Kim HS; Monk JP; Lemeshow SA; Gong M; Bahnson RR; Clinton SK
Urol Oncol; 2008; 26(2):125-32. PubMed ID: 18312929
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer.
Uzzo RG; Brown JG; Horwitz EM; Hanlon A; Mazzoni S; Konski A; Greenberg RE; Pollack A; Kolenko V; Watkins-Bruner D
BJU Int; 2004 May; 93(7):955-60. PubMed ID: 15142142
[TBL] [Abstract][Full Text] [Related]
3. Herbal and vitamin supplement use in a prostate cancer screening population.
Barqawi A; Gamito E; O'Donnell C; Crawford ED
Urology; 2004 Feb; 63(2):288-92. PubMed ID: 14972473
[TBL] [Abstract][Full Text] [Related]
4. Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trials.
Neuhouser ML; Kristal AR; Patterson RE; Goodman PJ; Thompson IM
Nutr Cancer; 2001; 39(1):12-8. PubMed ID: 11588893
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort.
Peters U; Littman AJ; Kristal AR; Patterson RE; Potter JD; White E
Cancer Causes Control; 2008 Feb; 19(1):75-87. PubMed ID: 17943452
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E supplements and risk of prostate cancer in U.S. men.
Rodriguez C; Jacobs EJ; Mondul AM; Calle EE; McCullough ML; Thun MJ
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):378-82. PubMed ID: 15006912
[TBL] [Abstract][Full Text] [Related]
7. Use of vitamins, minerals, and nutritional supplements by participants in a chemoprevention trial.
Sandler RS; Halabi S; Kaplan EB; Baron JA; Paskett E; Petrelli NJ
Cancer; 2001 Mar; 91(5):1040-5. PubMed ID: 11251957
[TBL] [Abstract][Full Text] [Related]
8. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence.
Van Patten CL; de Boer JG; Tomlinson Guns ES
J Urol; 2008 Dec; 180(6):2314-21; discussion 2721-2. PubMed ID: 18930254
[TBL] [Abstract][Full Text] [Related]
9. Use of nonprescription medications for perceived cardiovascular health.
Artz MB; Harnack LJ; Duval SJ; Armstrong C; Arnett DK; Luepker RV
Am J Prev Med; 2006 Jan; 30(1):78-81. PubMed ID: 16414428
[TBL] [Abstract][Full Text] [Related]
10. Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study.
Beebe-Dimmer JL; Wood DP; Gruber SB; Douglas JA; Bonner JD; Mohai C; Zuhlke KA; Shepherd C; Cooney KA
Urology; 2004 Feb; 63(2):282-7. PubMed ID: 14972472
[TBL] [Abstract][Full Text] [Related]
11. Use of multivitamins and prostate cancer mortality in a large cohort of US men.
Stevens VL; McCullough ML; Diver WR; Rodriguez C; Jacobs EJ; Thun MJ; Calle EE
Cancer Causes Control; 2005 Aug; 16(6):643-50. PubMed ID: 16049802
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model.
Waters DJ; Shen S; Glickman LT; Cooley DM; Bostwick DG; Qian J; Combs GF; Morris JS
Carcinogenesis; 2005 Jul; 26(7):1256-62. PubMed ID: 15817614
[TBL] [Abstract][Full Text] [Related]
13. The incidence of potential interactions between dietary supplements and prescription medications in cancer patients at a Veterans Administration Hospital.
Lee AH; Ingraham SE; Kopp M; Foraida MI; Jazieh AR
Am J Clin Oncol; 2006 Apr; 29(2):178-82. PubMed ID: 16601439
[TBL] [Abstract][Full Text] [Related]
14. Increasing trends in elderly persons' use of nonvitamin, nonmineral dietary supplements and concurrent use of medications.
Wold RS; Lopez ST; Yau CL; Butler LM; Pareo-Tubbeh SL; Waters DL; Garry PJ; Baumgartner RN
J Am Diet Assoc; 2005 Jan; 105(1):54-63. PubMed ID: 15635346
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer prevention: past, present, and future.
Fleshner N; Zlotta AR
Cancer; 2007 Nov; 110(9):1889-99. PubMed ID: 17893870
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of prostate cancer: agents and study designs.
Thompson IM
J Urol; 2007 Sep; 178(3 Pt 2):S9-S13. PubMed ID: 17644117
[TBL] [Abstract][Full Text] [Related]
17. Nutritional supplement use among 26-year-olds.
Allen T; Thomson WM; Emmerton LM; Poulton R
N Z Med J; 2000 Jul; 113(1113):274-7. PubMed ID: 10935566
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of prostate cancer.
Brand TC; Canby-Hagino ED; Pratap Kumar A; Ghosh R; Leach RJ; Thompson IM
Hematol Oncol Clin North Am; 2006 Aug; 20(4):831-43. PubMed ID: 16861117
[TBL] [Abstract][Full Text] [Related]
19. Common medications and prostate cancer mortality: a review.
Stopsack KH; Greenberg AJ; Mucci LA
World J Urol; 2017 Jun; 35(6):875-882. PubMed ID: 27492013
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of urological cancer.
Kamat AM; Lamm DL
J Urol; 1999 Jun; 161(6):1748-60. PubMed ID: 10332429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
